• Explore /
  • Poster
  • / Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM).

Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM).

Abstract Poster

Authors

null

Ahmed Idbaih

Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France

Ahmed Idbaih , Michael Canney , Carole Desseaux , Alexandre Vignot , Bruno Law-Ye , Delphine Leclercq , Lisa Belin , Anne Bissery , Yann De Ricke , Marc Sanson , Khe Hoang-Xuan , Caroline Dehais , Caroline Houillier , Florence Laigle-Donadey , Jean-Yves Delattre , Alexandre Carpentier

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT02253212

Citation

J Clin Oncol 36, 2018 (suppl; abstr 2016)

DOI

10.1200/JCO.2018.36.15_suppl.2016

Abstract #

2016

Poster Bd #

174

Abstract Disclosures

Similar Posters

First Author: Ahmed Idbaih

First Author: Kenneth H. Kim

First Author: Jianqing Zhu

First Author: Mason Webb